The Bcl-2 family and cell death regulation

Current Opinion in Genetics and Development

Volumn 8, Issue 1, 1998, Pages 68-75

  Newton, Kim ^a   Strasser, Andreas ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYSTEINE PROTEINASE; CYTOCHROME C; PROTEIN BCL 2; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; CAENORHABDITIS ELEGANS; CELL DEATH; ENZYME REGULATION; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; TRANSGENIC MOUSE;

EID: 0031889579     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(98)80064-6     Document Type: Article

References (92)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:1972;239-257.
2. Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell. 76:1994;777-779.
3. Strasser A. Life and death during lymphocyte development and function: evidence for two distinct killing mechanisms. Curr Opin Immunol. 7:1995;228-234.
4. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell. 88:1997;347-354.
5. Barr PJ, Tomei LD. Apoptosis and its role in human disease. Biotechnology. 12:1994;487-493.
6. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
7. Strasser A, Huang DCS, Vaux DL. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control in tumourigenesis and resistance to chemotherapy. Biochim Biophys Acta. 1333:1997;F151-F178.
8. Wyllie AH, Kerr JFR, Currie AR. Cell death; the significance of apoptosis. Int Rev Cytol. 68:1980;251-306.
9. Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode C. elegans. Cell. 44:1986;817-829.
10. Hengartner MO, Horvitz HR. Programmed cell death in Caenorhabditis elegans. Curr Opin Genet Dev. 4:1994;581-586.
11. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell. 75:1993;641-652.
12. Xue D, Shaham S, Horvitz HR. The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease. Genes Dev. 10:1996;1073-1083.
13. Hengartner MO, Ellis RE, Horvitz HR. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature. 356:1992;494-499.
14. Vaux DL, Weissman IL, Kim SK. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science. 258:1992;1955-1957.
15. Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell. 76:1994;665-676.
16. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:1993;597-608.
17. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to bcl-2. Proc Natl Acad Sci USA. 90:1993;3516-3520.
18. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
19. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Lutz RJ, Chinnadurai G. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene. 11:1995;1921-1928.
20. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC. Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 374:1995;733-736.
21. Farrow SN, White JHM, Martinou I, Raven T, Pun K-T, Grinham CJ, Martinou J-C, Brown R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature. 374:1995;731-733.
22. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature. 374:1995;736-739.
23. L and Bcl-2, displaces Bax and promotes cell death. Cell. 80:1995;285-291.
24. L, is a mammalian pro-survival protein. The discovery of multiple proteins of apparently similar function raises questions as to their different roles in vivo.
25. Han J, Sabbatini P, White E. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. of special interest Mol Cell Biol. 16:1996;5857-5864 This paper describes the pro-apoptotic protein Nbk/Bik, identified because of its ability to interact with the adenovirus homologue of Bcl-2, E1B 19K. Like previously identified pro-apoptotic proteins, Nbk/Bik binds to and antagonises the pro-survival function of Bcl-2. The surprising feature of these pro-apoptotic proteins is their lack of overall sequence similarity. These differences may represent their involvement in distinct pathways to apoptosis, perhaps allowing them to interact with diverse upstream signalling molecules.
26. Wang K, Yin X-M, Chao DT, Milliman CL, Korsmeyer SJ. BID: a novel BH3 domain-only death agonist. of special interest Genes Dev. 10:1996;2859-2869 This paper describes the cloning of Bid, another pro-apoptotic protein discovered because of its ability to bind to Bcl-2. Like Nbk/Bik, Bid's primary structure has limited features in common with those of other known pro-apoptotic proteins.
27. L. of special interest EMBO J. 16:1997;1686-1694 Describes the pro-apoptotic protein Hrk. This protein, like Nbk/Bik and Bid, was identified because of its ability to interact with anti-apoptotic members of the Bcl-2 protein family.
28. Shaham S, Horvitz HR. Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities. of outstanding interest Genes Dev. 10:1996;578-591 This paper describes genetic studies which delineated the order in which cell death genes act in the nematode. Specifically, that ced-9 acts upstream of ced-4, and that ced-4 acts upstream of, or parallel to ced-3. These findings provided important clues to interactions between the mammalian homologues of these genes.
29. Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poirier GG, Dixit VM. Molecular ordering of the cell death pathway. of special interest J Biol Chem. 271:1996;4573-4576 See annotation [32].
30. L. of special interest J Biol Chem. 271:1996;17601-17604 See annotation [32].
31. Orth K, Chinnaiyan AM, Garg M, Froelich CJ, Dixit VM. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate Lamin A. of special interest J Biol Chem. 271:1996;16443-16446 See annotation [32].
32. L act upstream of some caspases and, in this respect, are similar to CED-9, which acts upstream of the caspase CED-3 in C. elegans.
33. L complexed with either Bax, Bak or Bik, is unable to bind to CED-4.
34. Irmler M, Hofmann K, Vaux DL, Tschopp J. Direct physical interaction between the Caenorhabditis elegans death proteins ced-3 and ced-4. of outstanding interest FEBS Lett. 406:1997;189-190 The authors find that CED-4 can bind to the caspase CED-3. These experiments followed the identification of a a protein-protein interaction domain termed a caspase recruitment domain (CARD) in CED-3 and CED-4.
35. Seshagiri S, Miller LK. Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced apoptosis. of outstanding interest Curr Biol. 7:1997;455-460 The first paper to show that CED-4 is unable to promote CED-3 activation. This activity of CED-4 was inhibited by CED-9, with CED-9 able to bind to CED-4.
36. Spector MS, Desnoyers S, Hoeppner DJ, Hengartner MO. Interaction between the C. elegans cell-death regulators CED-9 and CED-4. of outstanding interest Nature. 385:1997;653-656 Describes the ability of CED-4 to bind to CED-9. The significance of this interaction is established by the analysis of ced-9 mutants, which finds that CED-4 binding correlates with CED-9 pro-survival function.
37. Wu D, Wallen HD, Nunez G. Interaction and regulation of subcellular localization of CED-4 by CED-9. of outstanding interest Science. 275:1997;1126-1129 This paper, like [36], focuses on the interaction of CED-4 with CED-9. Confocal microscopy and subcellular fractionation experiments suggest that this interaction allows CED-9 to localise CED-4 to nuclear and organelle membranes. The implication is that this property of CED-9, and perhaps other anti-apoptotic proteins, may be important for its pro-survival function.
38. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of Caspase-3. of outstanding interest Cell. 90:1997;405-413 This paper describes the purification and subsequent cloning of the protein Apaf-1 from HeLa cell cytosol. This protein was sought because of its ability to trigger caspase-3 activation in the presence of cytochrome c, dATP and Apaf in vitro. The discovery of Apaf-1 had considerable impact on the field of cell death research as it is a much sought after mammalian homologue of CED-4.
39. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. of outstanding interest Cell. 85:1996;803-815 See annotation [40].
40. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, et al. FLICE, a novel FADD homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. of outstanding interest Cell. 85:1996;817-827 References [39-40] demonstrate that caspase-8 is recruited to the CD95/Fas and TNRF1 signalling complexes by the cytoplasmic adaptor protein FADD/MORT1. Activation of caspase-8 represents a mechanism by which ligation of these receptors is able to trigger apoptosis.
41. Duan H, Dixit VM. RAIDD is a new 'death' adaptor molecule. Nature. 385:1997;86-89.
42. Chinnaiyan AM, Chaudhary D, O'Rourke K, Koonin EV, Dixit VM. Role of CED-4 in the activation of CED-3. of outstanding interest Nature. 388:1997;728-729 This paper, together with [35], demonstrates that CED-4 stimulates CED-3 autoactivation and identifies ATP and regions of CED-4 and CED-3 as requisites for CED-3 cleavage.
43. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 81:1995;495-504.
44. Yang X, Khosravi-Far R, Chang HY, Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. of outstanding interest Cell. 89:1997;1067-1076 This paper identifies Daxx as a protein that can bind to the CD95/Fas death domain and activate the JNK pathway, but surprisingly Daxx itself lacks a death domain. Unlike FADD/MORT1, Daxx appears to participate in an apoptotic pathway downstream of CD95/Fas that is Bcl-2-sensitive and does not involve caspase-8 activation.
45. Strasser A, Harris AW, Huang DCS, Krammer PH, Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14:1995;6136-6147.
46. Bertin J, Armstrong RC, Ottilie S, Martin DA, Wang Y, Banks S, Wang G-H, Senkevich TG, Alnemri ES, Moss B, et al. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. of outstanding interest Proc Natl Acad Sci USA. 94:1996;1172-1176 See annotation [47].
47. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer J-L, Schröster M, et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. of outstanding interest Nature. 386:1997;517-521 References [46,47] describe how some viruses interfere with the defences of the host by producing proteins that block caspase-8 activation downstream of members of the TNF receptor family.
48. Nava VE, Cheng EH-Y, Veliuona M, Zou S, Clem RJ, Mayer M, Hardwick JM. Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J Virol. 71:1997;4118-4122.
49. Cheng EH-Y, Nicholas J, Bellows DS, Hayward GS, Guo H-G, Reitz MS, Hardwick JM. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA. 94:1997;690-694.
50. White E, Sabbatini P, Debbas M, Wold WSM, Kusher DI, Gooding LR. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α Mol Cell Biol. 12:1992;2570-2580.
51. L and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene. 14:1997;405-414.
52. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A. Epstein virus-coded BHRF 1 protein, a viral homologue of Bcl-2 protects human B cells from programmed cell death. Proc Natl Acad Sci USA. 90:1993;8479-8483.
53. Knudson CM, Korsmeyer SJ. Bcl-2 and Bax function independently to regulate cell death. of special interest Nat Genet. 16:1997;358-363 This paper examines cells from Bcl-2-deficient mice, Bax-deficient mice and mice deficient in both proteins for their ability to undergo apoptosis. This work establishes that Bax can promote cell death in the absence of Bcl-2 and that Bcl-2 does not need Bax to promote cell survival.
54. L and related proteins may also form membrane pores. This is the first member of the Bcl-2 protein family to have its structure solved.
55. L forms an ion channel in synthetic lipid membranes. Nature. 385:1997;353-357.
56. Schendel SL, Xie Z, Oblatt-Montal M, Matsuyama S, Montal M, Reed JC. Channel formation by anti-apoptotic protein Bcl-2. Proc Natl Acad Sci USA. 94:1997;5113-5118.
57. Antonsson B, Conti F, Ciavatta A-M, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod J-J, Mazzei G, et al. Inhibition of Bax channel-forming activity by Bcl-2. of special interest Science. 277:1997;370-372 This paper shows that a truncated Bax mutant which lacks a carboxy-terminal hydrophobic domain behaves as a pore-forming protein at physiological pH and that Bcl-2 can block the effects of Bax on membranes.
58. Xiang J, Chao DT, Korsmeyer SJ. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc Natl Acad Sci USA. 93:1996;14559-14563.
59. McCarthy NJ, Whyte MKB, Gilbert CS, Evan GI. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol. 136:1997;215-227.
60. Chen-Levy Z, Nourse J, Cleary ML. The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol Cell Biol. 9:1989;701-710.
61. Chen-Levy Z, Cleary ML. Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. J Biol Chem. 265:1990;4929-4933.
62. De Jong D, Prins F, van Krieken HHJM, Mason DY, van Ommen G, Kluin PM. Subcellular localization of bcl-2 protein. Curr Topics Microbiol Immunol. 182:1992;287-292.
63. Monaghan P, Robertson D, Amos TAS, Dyer MJS, Mason DY, Greaves MF. Ultrastructural localization of BCL-2 protein. J Histochem Cytochem. 40:1992;1819-1825.
64. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53:1993;4701-4714.
65. De Jong D, Prins FA, Mason DY, Reed JC, van Ommen GB, Kluin PM. Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. Cancer Res. 54:1994;256-260.
66. Lithgow T, van Driel R, Bertram JF, Strasser A. The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum and the outer mitochondrial membrane. Cell Growth Differ. 5:1994;411-417.
67. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer S. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 74:1993;241-251.
68. Nguyen M, Branton PE, Walton PA, Oltvai ZN, Korsmeyer SJ, Shore GC. Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. J Biol Chem. 269:1994;16521-16524.
69. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. of outstanding interest Cell. 86:1996;147-157 The authors of this paper describe a cell-free system in which cytochrome c is essential for caspase-3 activation and demonstrates that cytochrome c levels in the cytosol increase when cells are induced to undergo apoptosis with staurosporine.
70. Kluck RM, Bossy Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. of outstanding interest Science. 275:1997;1132-1136 The authors demonstrate that cytochrome c released from mitochondria in a Xenopus cell-free system is able to trigger caspase-3 activation in the presence of other cytosolic factors. Bcl-2 prevents this cytochrome c release and associated apoptotic changes. These observations infer that Bcl-2 promotes cell survival by regulating caspase activation.
71. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP, Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. of outstanding interest Science. 275:1997;1129-1132 This reference describes the release of cytochrome c from the mitochondria of cells induced to undergo apoptosis by staurosporine treatment. The dependence of the apoptotic program on cytochrome c release was demonstrated by the inability of cell free extracts depleted of cytochrome c to initiate caspase-mediated cleavage events. Bcl-2 was shown to block cytochrome c release and apoptosis, indicating that this may be an important aspect of its pro-survival function.
72. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. of outstanding interest Cell. 89:1997;175-184 The paper details the discovery of a protein, DFF, that is a substrate of caspase-3 and that is activated by proteolytic cleavage. Active DFF promotes internucleosomal DNA fragmentation in isolated nuclei, but not having endonuclease activity itself must activate a downstream endonuclease. This finding therefore elucidates a route form caspases to DNA fragmentation, a commonly observed feature in apoptotic cells.
73. Rudel T, Bokoch GM. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. of outstanding interest Science. 276:1997;1571-1574 This paper demonstrates that the serine-threonine kinase PAK2 is activated by caspase-3 cleavage and that some of the morphological changes characteristic of apoptotic cells are blocked by a dominant-negative PAK2 mutant.
74. L.
75. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. of special interest J Exp Med. 184:1996;1331-1341 This paper describes a 50kDa protease, AIF, that is released from mitochondria induced to undergo permeability transition in a cell-free system. AIF can trigger caspase-3 activation and internucleosomal DNA fragmentation in isolation and its release from mitochondria is blocked by Bcl-2.
76. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:1988;440-442.
77. Rodriguez I, Araki K, Khatib K, Martinou J-C, Vassalli P. Mouse vaginal opening is an apoptosis-dependent process which can be prevented by the overexpression of Bcl2. Dev Biol. 184:1997;115-121.
78. Furuchi T, Masuko K, Nishimune Y, Obinata M, Matsui Y. Inhibition of testicular germ cell apoptosis and differentiation in mice misexpressing Bcl-2 in spermatogonia. Development. 122:1996;1703-1709.
79. Rodriguez I, Ody C, Araki K, Garcia I, Vassalli P. An early and massive wave of germinal cell apoptosis is required for the development of functional spermatogenesis. EMBO J. 16:1997;2262-2270.
80. Strasser A, Harris AW, Corcoran LM, Cory S. bcl-2 expression promotes B but not T lymphoid development in scid mice. Nature. 368:1994;457-460.
81. Young F, Mizoguchi E, Bhan AK, Alt FW. Constitutive Bcl-2 expression during immunoglobulin heavy chain-promoted B cell differentiation expands novel precursor B cells. Immunity. 6:1997;23-33.
82. Tarlinton DM, Corcoran LM, Strasser A. Cell survival and cell differentiation during B lymphopoiesis are subject to distinct control. Int Immunol. 9:1997;1481-1494.
83. Lagasse E, Weissman IL. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. of outstanding interest Cell. 89:1997;1021-1031 See annotation [86].
84. Akashi K, Kondo M, von Freeden-Jeffry U, Murray R, Weissman IL. Bcl-2 rescues T lymphopoiesis in Interleukin-7 receptor-deficient mice. of outstanding interest Cell. 89:1997;1033-1041 See annotation [86].
85. -/- mice. of outstanding interest Cell. 89:1997;1011-1019 See annotation [86].
86. Kondo M, Akashi K, Domen J, Sugamura K, Weissman IL. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common γ chain-deficient mice. of outstanding interest Immunity. 7:1997;155-162 The authors of references [83-86] describe how a bcl-2 transgene can rescue some of the defects associated with cytokine or cytokine receptor deficient animals. They indicate that the essential role of some cytokines may be to provide cells with a survival signal.
87. Von Freeden-Jeffry U, Solvason N, Howard M, Murray R. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. of special interest Immunity. 7:1997;147-154 This reference examines Bcl-2 expression in immature thymocytes from IL-7-deficient mice. Loss of Bcl-2 expression is found to correlate with the early defect in T cell development in these mice suggesting that Bcl-2 may be an important downstream target of the IL-7 receptor in these cells.
88. Yasutomo K, Maeda K-I, Hisaeda H, Good RA, Kuroda Y, Himeno K. The Fas-deficient SCID mouse exhibits the development of T cells in the thymus. J Immunol. 158:1997;4729-4733.
89. Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 277:1997;559-562.
90. Ellis RE, Horvitz HR. Two C. elegans genes control the programmed deaths of specific cells in the pharynx. Development. 112:1991;591-603.
91. Metzstein MM, Hengartner MO, Tsung N, Ellis RE, Horvitz HR. Transcriptional regulator of programmed cell death encoded by Caenorhabditis elegans gene ces-2. of special interest Nature. 382:1996;545-547 This paper describes the cloning and characterisation of CES-2, a transcription factor that acts upstream of CED-3, CED-4 and CED-9 in the nematode cell death pathway.
92. Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. of outstanding interest Nature. 385:1997;637-640 This paper demonstrates for the first time that Bax is a tumour-suppressor protein which acts downstream of the tumour-suppressor p53.